TNF and Crohn disease: Infliximab, a monoclonal antibody to TNF-α, is a biologic agent that has been approved for use in rheumatoid arthritis, Crohn's disease, and ankylosing spondylitis and has been proposed for the treatment of different types of ocular inflammation through binding and neutralizing the effect of TNF-α, with promising results [7].